Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Effectiveness of Style 410 Silicone-Filled Breast Implant Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Allergan ( Allergan Medical )
ClinicalTrials.gov Identifier:
NCT00690339
First received: June 2, 2008
Last updated: October 6, 2014
Last verified: December 2013
Results First Received: December 17, 2013  
Study Type: Interventional
Study Design: Allocation: Non-Randomized;   Endpoint Classification: Safety/Efficacy Study;   Intervention Model: Single Group Assignment;   Masking: Open Label
Conditions: Breast Augmentation
Breast Reconstruction
Revision of Augmentation or Reconstruction
Intervention: Device: Style 410 Silicone-Filled Breast Implants

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Augmentation

Augmentation

Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery

Reconstruction

Reconstruction

Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery

Revision-augmentation

Revision-augmentation

Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery

Revision-reconstruction

Revision-reconstruction

Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery


Participant Flow:   Overall Study
    Augmentation   Reconstruction   Revision-augmentation   Revision-reconstruction
STARTED   492   225   156   68 
COMPLETED   375   144   99   43 
NOT COMPLETED   117   81   57   25 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Augmentation

Augmentation

Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery

Reconstruction

Reconstruction

Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery

Revision-augmentation

Revision-augmentation

Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery

Revision-reconstruction

Revision-reconstruction

Style 410 Silicone-Filled Breast Implants: Breast Implant Surgery

Total Total of all reporting groups

Baseline Measures
   Augmentation   Reconstruction   Revision-augmentation   Revision-reconstruction   Total 
Overall Participants Analyzed 
[Units: Participants]
 492   225   156   68   941 
Age 
[Units: Subjects]
         
<=18 years   0   0   0   0   0 
Between 18 and 65 years   492   218   156   65   931 
>=65 years   0   7   0   3   10 
Gender 
[Units: Subjects]
         
Female   492   225   156   68   941 
Male   0   0   0   0   0 


  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Local Complications   [ Time Frame: 10 years ]

2.  Secondary:   Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale.   [ Time Frame: 10 years ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information